A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors
Clinical trial NCT00880321 · COMPLETED
Trial details
- NCT number
- NCT00880321
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-04
- Primary completion
- 2011-03-25
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.